SavedAdd your journal

Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2020 / Cilt: 73 - Sayı: 2

Increased Galectin-3 Levels Predicts Ventricular Arrhythmic Events Following ST-elevation Myocardial İnfarction

Artmış Galektin-3 Düzeyleri, ST Elevasyonlu Miyokart Enfarktüsünü Takiben Gelişen Ventriküler Aritmik Olayları Öngörür

İsmail BOLAT
Hamdi PUSUROĞLU
Pages
124–129
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Low-Gal-3 andhigh-Gal-3 groups were compared with respect to both MTWA and PVC positivity and their association with Gal-3 levels were examined.Results: When compared to the low-Gal-3 group, left atrial volume (LAV) was higher in the high-Gal-3 patients (55.7±18.0 vs 40.6±13.7 mL,p35%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We aimed to determine the association between Galectin-3 (Gal-3) levels and microvolt T-wave alternans (MTWA) and frequentpremature ventricular complexes (PVCs) in single-vessel patients with left ventricular ejection fraction (EF) (LVEF) >35%, who presented with STelevated myocardial infarction (MI) (STEMI) and were treated with primary percutane-ous coronary intervention (pPCI).Materials and Methods: A total of 81 patients were included in this cross-sectional study.
📊
Key Findings & Data:Blood samples for Gal-3 levels were obtained from allpatients at the time of admission.
💡
Conclusion & Impact:Low-Gal-3 andhigh-Gal-3 groups were compared with respect to both MTWA and PVC positivity and their association with Gal-3 levels were examined.Results: When compared to the low-Gal-3 group, left atrial volume (LAV) was higher in the high-Gal-3 patients (55.7±18.0 vs 40.6±13.7 mL,p35%.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We aimed to determine the association between Galectin-3 (Gal-3) levels and microvolt T-wave alternans (MTWA) and frequentpremature ventricular complexes (PVCs) in single-vessel patients with left ventricular ejection fraction (EF) (LVEF) >35%, who presented with STelevated myocardial infarction (MI) (STEMI) and were treated with primary percutane-ous coronary intervention (pPCI).Materials and Methods: A total of 81 patients were included in this cross-sectional study. Blood samples for Gal-3 levels were obtained from allpatients at the time of admission. The patients were separated into low and high Gal-3 (≤ and >1.93 ng/dL, respectively) groups. Low-Gal-3 andhigh-Gal-3 groups were compared with respect to both MTWA and PVC positivity and their association with Gal-3 levels were examined.Results: When compared to the low-Gal-3 group, left atrial volume (LAV) was higher in the high-Gal-3 patients (55.7±18.0 vs 40.6±13.7 mL,p35%.

Özet

Amaç: Sol ventrikül ejeksiyon fraksiyonu (EF) (LVEF) >%35 ve tek damar tıkanıklığı olan ve primer perkütan koroner girişim (pPCI) ile tedavi edilen ST segment elevasyonlu miyokart enfarktüsü (MI) (STEMI) hastalarında, Galektin-3 (Gal-3) düzeyleri ile mikrovolt T dalga alternans (MTWA) ve sık prematüre ventriküler kompleksler (PVC) arasındaki ilişkiyi belirlemeyi amaçladık. Gereç ve Yöntem: Bu kesitsel çalışmaya toplam 81 hasta dahil edildi. Başvuru anında tüm has talardan Gal-3 düzeyleri için kan örnekleri alındı. Hastalar düşük ve yüksek Gal-3 (sırasıyla ≤ ve > 1,93 ng/dL) gruplarına ayrıldı. Düşük Gal-3 ve yüksek Gal-3 grupları hem MTWA hem de PVC pozitifliği açısından karşılaştırılmış ve Gal-3 düzeyleri ile ilişkisi incelenmiştir. Bulgular: Düşük Gal-3 grubu ile karşılaştırıldığında, yüksek Gal-3 hastalarında sol atriyal hacim (LAV) daha yüksekti (55,7±18,0’a karşı 40,6±13,7 mL, p%35 olan tek damarlı STE-MI hastalarında aritmik olayların bir prediktörü idi.

🔖

Cite This Article

BOLAT, İ., PUSUROĞLU, H. (2022). Increased Galectin-3 Levels Predicts Ventricular Arrhythmic Events Following ST-elevation Myocardial İnfarction. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 73 - Sayı: 2, 124–129. https://ajindex.com/articles/443530

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. McManus DD, Gore J, Yarzebski J, et al. Recent trensds in the incidence,treatment,and outcomes of patients with STEMI and NSTEMI.Am J Med. 2011;124:40-47
  2. Jerberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with St-elevation myocardial infarction. JAMA. 2011;305:1677-1684
  3. Bolognese L, Neskovic AN, Parodi G, et al. Left ventricular remodelling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation. 2002;106:2351-2357
  4. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36:2793-2867
  5. Stecker EC, Vickers C, Waltz J, et al. Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: twoyear findings from the Oregon Sudden Unexpected Death Study. J Am Coll Cardiol. 2006;47:1161-1166
  6. Chow T, Kereiakes DJ, Bartone C, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol. 2006;47:1820-1827
  7. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 1993;87:312-322
  8. Dumic J, Dabelic S, Flogel M. Galectin-3:an open-ended story. Biochim Biophys Acta. 2006;1760:616-635
  9. Pusuroglu H, Akgul O, Erturk M, et al. Assessment of relationship between galectin-3 and ambulatory ECG-based microvolt T-wave alternans in sustained systodiastolic hypertension patients. Blood Press Monit. 2016;21:265-270
  10. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with STsegment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177
  11. Szadkowska I, Wlazel RN, Migala M, et al. The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty. Cardiol J. 2013;20,6:577-582
  12. Cohn JN, Ferrari R, Sharpe N. Cardiac remodelling-concepts and clinical implications:a consens